UNICA IRIS Institutional Research Information System

DEFAZIO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 174.755
NA - Nord America 15.626
AS - Asia 7.725
SA - Sud America 1.977
AF - Africa 224
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 3
Totale 200.335
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 171.499
US - Stati Uniti d'America 15.261
SG - Singapore 3.203
CN - Cina 2.148
BR - Brasile 1.550
VN - Vietnam 967
SE - Svezia 652
FR - Francia 424
UA - Ucraina 410
DE - Germania 406
FI - Finlandia 364
GB - Regno Unito 354
HK - Hong Kong 308
CA - Canada 208
IN - India 195
AR - Argentina 168
NL - Olanda 161
TR - Turchia 122
BD - Bangladesh 101
KR - Corea 97
MX - Messico 88
JP - Giappone 80
EC - Ecuador 77
RU - Federazione Russa 71
ID - Indonesia 70
IQ - Iraq 70
AT - Austria 67
ZA - Sudafrica 63
ES - Italia 56
CO - Colombia 51
PL - Polonia 45
PK - Pakistan 44
PH - Filippine 40
MA - Marocco 37
SA - Arabia Saudita 36
VE - Venezuela 32
CL - Cile 30
CH - Svizzera 29
IE - Irlanda 29
UZ - Uzbekistan 28
EG - Egitto 27
IR - Iran 27
PY - Paraguay 27
RO - Romania 27
AE - Emirati Arabi Uniti 22
PE - Perù 22
BE - Belgio 21
KE - Kenya 21
CZ - Repubblica Ceca 20
IL - Israele 20
MY - Malesia 20
AL - Albania 17
TN - Tunisia 17
NP - Nepal 16
TW - Taiwan 16
JM - Giamaica 15
AU - Australia 14
GR - Grecia 14
JO - Giordania 13
DO - Repubblica Dominicana 12
DZ - Algeria 12
AZ - Azerbaigian 11
BG - Bulgaria 11
NZ - Nuova Zelanda 11
PT - Portogallo 11
KZ - Kazakistan 10
RS - Serbia 10
CR - Costa Rica 9
ET - Etiopia 9
LT - Lituania 9
UY - Uruguay 9
BO - Bolivia 8
PA - Panama 8
PS - Palestinian Territory 8
HU - Ungheria 7
LB - Libano 7
NG - Nigeria 7
OM - Oman 7
TH - Thailandia 7
GH - Ghana 6
KG - Kirghizistan 6
MG - Madagascar 6
DK - Danimarca 5
HN - Honduras 5
HR - Croazia 5
LV - Lettonia 5
QA - Qatar 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
EE - Estonia 4
GT - Guatemala 4
KH - Cambogia 4
SY - Repubblica araba siriana 4
MU - Mauritius 3
SN - Senegal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
Totale 200.291
Salva come PNG Salva come JPEG
Città #
Cagliari 161.206
Uta 5.701
Fairfield 2.306
Ashburn 1.501
Singapore 1.275
Woodbridge 982
Seattle 895
Boardman 816
Houston 815
Dallas 763
Wilmington 755
Cambridge 740
San Jose 733
Nyköping 496
Ann Arbor 444
Beijing 427
Milan 402
Rome 387
Helsinki 338
Ho Chi Minh City 322
Chandler 321
The Dalles 311
Los Angeles 302
Hong Kong 265
Lauterbourg 238
Shanghai 224
Hanoi 220
New York 220
Boston 217
Jacksonville 213
Nanjing 165
Buffalo 154
São Paulo 149
Guangzhou 147
Santa Clara 147
Munich 125
San Diego 123
Council Bluffs 117
Toronto 116
Dearborn 111
Naples 102
Turin 85
London 81
Redwood City 79
Bologna 75
Catania 71
Florence 64
Millbury 63
Shenyang 59
Norwalk 57
Tianjin 57
Bari 56
Dong Ket 56
Trabzon 56
Seoul 54
Augusta 53
Changsha 52
Hefei 52
Nuremberg 49
Chicago 48
Frankfurt am Main 48
Rio de Janeiro 45
Tokyo 45
Verona 44
Orem 41
Haiphong 40
Jiaxing 40
Palermo 40
Da Nang 39
Hebei 39
Redondo Beach 38
Nanchang 37
Vienna 33
Curitiba 32
Padova 32
San Mateo 31
Brasília 30
Chennai 30
Genoa 30
Guayaquil 30
Wuhan 29
Atlanta 28
Belo Horizonte 28
Montreal 28
Mountain View 26
Tashkent 25
Brescia 24
Phoenix 24
Sassari 24
Shenzhen 24
Baghdad 23
Biên Hòa 23
Brooklyn 23
Denver 23
Düsseldorf 23
Hải Dương 23
Mexico City 23
Parma 23
Johannesburg 22
Mumbai 22
Totale 187.690
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.353
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with Parkinson’s disease 4.464
Neurosifilide e stroke ischemico: case report. 3.759
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.341
Olfactory function and apathy as potential biomarker in patients with Parkinson's disease 3.033
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.748
Epilessia mioclonica progressiva o epilessia parziale continua? 2.499
Gender differences in olfactory function in patients with Parkinson's disease. 2.468
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease 2.370
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.360
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 2.330
Sleep cardiac dysautonomia and EEG oscillations in Amyotrophic Lateral Sclerosis 2.267
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.265
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.199
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 2.162
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 2.127
Gender differences in olfactory dysfunctions in Sardinian patients affected by Parkinson’s disease 2.113
CORRELATION AMONG OLFACTORY DYSFUNCTION, APATHY AND FATIGUE IN PATIENTS WITH PARKINSON’S DISEASE 2.086
Upper limb movements in dementia with Lewy body: a quantitative analysis 1.971
Sensory trick in upper limb dystonia 1.967
Pulvinar sign in a case of anti-CV2 encephalitis 1.906
A “Catastrophic” Heparin-Induced Thrombocytopenia 1.885
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.754
NCSE: un caso di steroid-responsive encephalopathy associated with autoimmune thyroiditis 1.724
Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effect 1.662
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.645
Geographic differences in the incidence of Huntington's disease in Sardinia, Italy 1.592
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 1.558
Internal carotid artery dissection causing ischemic stroke during pole sport practice 1.556
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 1.550
Carotid plaque imaging profiling in subjects with risk factors (diabetes and hypertension) 1.531
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 1.424
The Relationships Between Ataxia and Cognition in Spinocerebellar Ataxia Type 2 1.408
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 1.296
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 1.275
Cerebellar Syndrome Associated with Thyroid Disorders 1.223
Does the network model fits neurophysiological abnormalities in blepharospasm? 1.222
Serum anti-thyroid antibodies in Hashimoto’s encephalopathy: A never-ending story 1.219
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 1.173
Cannabinoids and dystonia: an issue yet to be defined 1.164
Idiopathic Non-Task-Specific Upper Limb Dystonia, a Neglected Form of Dystonia 1.160
Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence. 1.145
Functional neurological disorder after COVID-19 vaccination 1.089
Movement disorders phenomenology in focal motor seizures 1.080
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 1.048
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 1.048
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest? 1.009
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 961
The role of sensory information in the pathophysiology of focal dystonias 960
Status epilepticus in Hashimoto's encephalopathy 949
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease 947
Therapeutic Use of Cerebellar Intermittent Theta Burst Stimulation (iTBS) in a Sardinian Family Affected by Spinocerebellar Ataxia 38 (SCA 38) 946
Effects of White Matter Hyperintensities on Brain Connectivity and Hippocampal Volume in Healthy Subjects According to Their Localization 942
Qualitative smell/taste disorders as sequelae of acute COVID-19 892
Persistent myoclonic jerks: a case of epilepsia partialis continua or myoclonic progressive epilepsy? 890
Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm 881
Diagnostic criteria for blepharospasm: A multicenter international study 881
Reshaping cortical connectivity in traumatic spinal cord injury: a novel effect of hyperbaric oxygen therapy 876
Effetti della stimolazione del nervo vago sulle componenti aperiodiche dell’EEG in soggetti affetti da epilessia resistente ai farmaci 864
Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients 863
Disease progression in blepharospasm: a 5-year longitudinal study 858
Risk factors of Parkinson disease. Simultaneous assessment, interactions, and etiologic subtypes 853
Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study 839
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 832
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 794
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature 790
Is Adult-Onset Dystonia a Rare Disease? Time for Population-Based Studies 767
Pain in Parkinson's disease: facts and uncertainties 751
Rasagiline withdrawal Syndrome in Parkinson’s Disease 748
23. Effects of vagal nerve stimulation on EEG aperiodic parameters in subjects affected by drug-resistant epilepsy 747
Validation of a guideline to reduce variability in diagnosing cervical dystonia 744
Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson’s Disease 727
Neuroimaging in idiopathic adult-onset focal dystonia 725
Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age-sex interaction and spatial-temporal variability 706
Neurological phenomenology of the IRF2BPL mutation syndrome: Analysis of a new case and systematic review of the literature 688
Pain in focal dystonias - A focused review to address an important component of the disease 681
Global Fractional Anisotropy: Effect on Resting-state Neural Activity and Brain Networking in Healthy Participants 681
Whole-exome sequencing for variant discovery in blepharospasm 680
The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes 678
Early juvenile reading epilepsy and later frontotemporal dementia (FTD): expanding the clinical phenotype of C9ORF72 mutation? 677
Estimated EEG functional connectivity and aperiodic component induced by vagal nerve stimulation in patients with drug-resistant epilepsy 668
The mid-term effects of carotid endarterectomy on cognition and regional neural activity analyzed with the amplitude of low frequency fluctuations technique 663
Functional gait disorders: Demographic and clinical correlations 650
Olfactory hallucinations in Parkinson’s disease patients and the role of their evaluation in clinical practice. 641
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non‑tremor‑dominant subtypes really uncorrelated to olfactory impairment? 640
Incidence and spatial distribution of adult-onset primary malignant and other central nervous system tumors in Southern Sardinia, Italy 638
Motor and non-motor symptoms in blepharospasm: clinical and pathophysiological implications 624
Functional neurological disorders as seen by a cohort of general practitioners in northern italy: Evidence from an online survey 617
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease 608
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 596
A neural network-based software to recognise blepharospasm symptoms and to measure eye closure time 580
Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder 578
Effect of botulinum toxin on non-motor symptoms in cervical dystonia 577
The Italian Dystonia Registry: rationale, design and preliminary findings 569
Does epilepsy contribute to the clinical phenotype of C9orf72 mutation in fronto-temporal dementia? 566
Cocaine-induced Pisa syndrome 564
Smoking and age-at-onset of both motor and non-motor symptoms in Parkinson's disease 560
Involuntary Thumb Flexion on Neurological Examination: An Unusual Form of Upper Limb Dystonia in the Faroe Islands 554
Blepharospasm 40 years later 550
The association between white matter hyperintensities, cognition and regional neural activity in healthy subjects 544
Totale 149.033
Salva come PNG Salva come JPEG
Categoria #
all - tutte 310.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 310.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.748 0 0 0 0 0 0 0 0 0 0 2.348 1.400
2021/202212.330 1.238 1.000 644 773 987 875 983 744 940 1.152 1.389 1.605
2022/202319.596 1.827 2.335 2.144 1.487 1.453 1.613 1.089 2.658 1.171 1.325 1.535 959
2023/202425.018 1.230 906 1.098 2.041 2.370 3.627 4.003 1.727 1.174 1.800 2.619 2.423
2024/202563.650 16.422 11.979 13.964 7.540 3.018 3.629 4.114 268 840 912 403 561
2025/202612.540 1.149 434 1.871 1.923 915 925 2.313 627 1.042 1.320 21 0
Totale 201.445